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Introduction
Monogenic autoinflammatory diseases are a group of
genetic conditions characterized by a dysregulation of
inflammatory response that include more than 20 diseases.
Despite the fact that they are different clinical entities, sev-
eral signs and symptoms are shared, making their differential
diagnosis difficult. Moreover, in most cases, a definitive diag-
nosis is exclusively achieved by a positive genetic study. The
need to analyze different genes makes this process costly in
terms of both time and money. The arrival of next genera-
tion sequencing into clinics can overcome these problems.
Objective
To develop a complete workflow to analyze simultaneously
the most common autoinflammatory-associated genes.
Materials and methods
A panel of 80 different primer pairs was designed accord-
ing to AccessArray™ and PGM Ion Torrent platform spe-
cifications. This panel covers MEFV (all exons except 2),
TNFRSF1A (exons 2-to-7), MVK (all exons), NLRP3 (all
exons), NOD2 (exons 4, 8, 11) and PSTPIP1 (exons 10-11)
genes. Libraries were prepared using 48.48 AccessArray™
chips and sequenced in the PGM platform using 400 bp
kits. Quality control, mapping and variant calling were
performed using Torrent Server and variant annotation
using Ion Reporter Suite. Coverage information was ana-
lyzed with BEDtools software.
A set of 25 control samples was used to validate our
sequencing and data analysis workflow. Then, a total of
288 patient samples were analyzed. Any possible disease-
causing mutation detected was confirmed by Sanger
sequencing.
Results
The results obtained in control samples were concordant
with the expected known genotypes. All germline muta-
tions (100%) and 4 out of 5 somatic mutations (80%) were
detected. Only a sample harboring extremely-low somatic
NLRP3 mosaicism (less than 4%) was not initially called by
our pipeline. In the analysis of 288 samples, all mutations
detected were confirmed by Sanger sequencing. Moreover,
in one of the analyzed patients, a somatic NLRP3 mutation
(12%) was identified in the routine screening.
Conclusion
We have designed a complete workflow to simultaneously
analyze the most common autoinflammatory-associated
genes in a clinical setting. This workflow allowed us to iden-
tify all of the germline mutations and most of the somatic
mutations previously detected in our control group. All the
detected mutations in new samples where confirmed by
Sanger sequencing. This NGS-based approach also enabled
us to detect a novel case of somatic NLRP3 mosaicism in a
patient with disease symptoms compatible with CAPS.
Published: 28 September 2015
doi:10.1186/1546-0096-13-S1-O81
Cite this article as: Gonzalez-Roca et al.: Development of a workflow to
analyze autoinflammatory-associated genes using AccessArray™™
system and next generation sequencing. Pediatric Rheumatology 2015
13(Suppl 1):O81.
Hospital Clinic, Immunology, Barcelona, Spain
Gonzalez-Roca et al. Pediatric Rheumatology 2015, 13(Suppl 1):O81
http://www.ped-rheum.com/content/13/S1/O81
© 2015 Gonzalez-Roca et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided
the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
